Possibly. But the pivotal trial will have the data that is sent for FDA approval. And I’m pretty sure they are doing a 6 month trial for pivotal as well. Usually these trials last anywhere from 1-3 years but exceptions are possible for certain types of treatments. Either way if this optimization study is almost don’t we could get this treatment by 2020.
Follica News (small Molecule Aplify New Hair Growth) - Annual Report And Accounts - Puretech Health
- Thread starter Left4bald
- Start date
- Reaction score
- 213
They create new hair (follicles). 100 new hairs per cm2, but only ~ 25 will become terminal. They write that they increased the amount of hair with the help of wnt molecula.. maybe samumed sm04554?
- Reaction score
- 392
Hi
Indeed, they can create new hair follicles, 100 news hairs per cm2 and only 25 become terminal but it was with minoxidil !
Here, they are developing their own wnt small molecule based on follica's intellectual property. This is not Sm04554
- Reaction score
- 392
I don't know if you are saying that Follica has made 5% more progress in their clinical development since last year... but the 63% means that PureTech Health has a right to royalty payments as a percentage of net sales from Follica. The percentage is for puretech health not for follica's progress.
I don't know but from what I have read, they have a:
" Proprietary device developed and optimal paradigm designed based on clinical data"
" Near-term clinical development of a “game changing” platform "
New hairs means it is a new hair follicle (neogenesis) from scratch. But they are also reviving miniaturized hairs too according to their patents!
" Follica has preclinical data which show the potential for next-generation proprietary compounds to further enhance the effect of new hair follicle formation. Follica completed its clinical-stage development of a next-generation device and drug combination product for androgenetic alopecia, which is currently in an optimisation study "
H
Senior Member
- Reaction score
- 775
A restaurant in a small town North of where I live has the best mushroom swiss burger in the world...or so they say, the people selling it that is.
- Reaction score
- 199
Will Follica in theory be able to also regrow the temples and hairline? Or is the regrowth mainly focussed on the crown?
HairlossCurse
Member
- Reaction score
- 39
Phase 3 usually includes 1000s of participants in clinical setting, so almost semi release. Pretty high chance US forum member will be able to get in... Man might go over to America, will get paid to get new hair. (Participants are usually paid as well)
- Reaction score
- 969
Well, those new chemicals need to go through all FDA approval phases, so see you around 2028 but until then you can enjoy those 25 hairs...
This treatment is and has always been ridiculous as:
1) The device causes scar tissue.
2) 25 terminal hairs per cm2 is terrible density, draw a 1cmx1cm square and put 25 dots in it to see how bad.
3) Due to 1) you would won't be applying this multiple times to get better density.
1) The device causes scar tissue.
2) 25 terminal hairs per cm2 is terrible density, draw a 1cmx1cm square and put 25 dots in it to see how bad.
3) Due to 1) you would won't be applying this multiple times to get better density.
- Reaction score
- 64
How are you sure about that?
- Reaction score
- 64
Are these “new chemicals” going to contain minoxidil does anybody know?
It has been quoted by Follica themselves in one of the many previous threads on this where they said they're trying to minimise scar tissue with the device but it's going to be pretty much impossible considering how deep they go.
I think its 5mm or something crazy like that.
I will decipher the marketing speak for you guys. Pay close attention to what is being said and what is not.
Follica has completed clinical stage development of a device and drug combination. This is referenced in paragraph 2 quoted above.
Follica has pre-clinical data for next-gen combounds which are much more potent. This is referenced in paragraphs 1 and 3 quoted above.
These two compounds are not the same.
This is also indicated by the fact that one has completed clinical development and the other has only pre-clinical data.
The marketing release is confusing on purpose, but please pay attention to what exactly is being said and what is not.
- Reaction score
- 338
Its not clear what depths their product will use but their patent covers depths of up to 5mm.. It's likely its still undergoing optimization in their optimization study.
I was worried about this too. Whatever their next gen compound is it will likely need its own approval.
- Reaction score
- 213
it seems the next generation is Switch Biotech
http://www.switch-biotech.com/Clinical Development.html
minimum 6 years. But unforgettable about wnt Samumed.
and yet it looks like an intentional prolongation of time.
fairy tale lasts 15 years.
http://www.switch-biotech.com/Clinical Development.html
minimum 6 years. But unforgettable about wnt Samumed.
and yet it looks like an intentional prolongation of time.
fairy tale lasts 15 years.
Sanchez1234
Experienced Member
- Reaction score
- 311
There is nothing new with this product.
People combined wounding and wnt (like lcl, vpa, WAY) and is does help. But dont expect a miracle.
People combined wounding and wnt (like lcl, vpa, WAY) and is does help. But dont expect a miracle.
Baldybald1
Established Member
- Reaction score
- 76
Then Dr. Bhanusali is offering Follica treatment as a clinical trial soon, does that mean he is going to use next generation compound?